Please login to the form below

Not currently logged in
Email:
Password:

Rock Unlimited appoints Ben Fisher as its director

Joins Terry Bradley and Clare Peck on the Rock Unlimited board

Ben Fisher RockBen Fisher has been appointed as med comms agency Rock Unlimited's new director. 

Fisher brings with him an innovative approach to scientific engagement and 13 years' experience within healthcare communications. 

He has held senior roles across Omnicom (Porter Novelli) and WPP (Ogilvy Healthworld) and more recently a stint at the Hive Group.

Terry Bradley, managing director at Rock Unlimited, said: “Ben is the ideal person to join the growing team. He brings a passion for healthcare communication, great enthusiasm for his work and a first class client service ethic.” 

Fisher has been involved in many educational programmes including disease awareness, message development, educational games, patient support programmes, product launches and digital platforms.

Catherine Warne, CEO of Health Unlimited, said: “The Health Unlimited mission is to connect healthcare brands with their key stakeholders through a bespoke team of specialists.  Ben's multi-disciplinary approach ensures scientific rigor is aligned with intelligent innovation leading to creative and insightful campaigns.”

Ben joins Terry Bradley and Clare Peck on the Rock Unlimited board. 

15th June 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics